- Tytuł:
- Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases November 2013 13(11):927-935
Czasopismo naukowe